Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsTrendsHealth

AstraZeneca joins hands with RGCI to treat leukaemia patients

As part of the programme, the drug maker aims to help identify and support CLL reference laboratories (CRLs) in strategic locations across India and connect peripheral hospitals with them.

October 19, 2021 / 02:03 PM IST
Source: Reuters

Source: Reuters

Drug firm AstraZeneca India on Tuesday said it has joined hands with Rajiv Gandhi Cancer Institute (RGCI) for an initiative to help diagnose and treat patients with chronic lymphocytic leukaemia (CLL).

Under the Project Chariot, the partners would roll out the initiative across North India and the Delhi NCR region.

As part of the programme, the drug maker aims to help identify and support CLL reference laboratories (CRLs) in strategic locations across India and connect peripheral hospitals with them.

CLL is a type of cancer that starts from the very cells that form into white blood cells called lymphocytes.